Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
243.50    -5.00 (-2.01%)
Bid:
241.00
Ask:
245.50
Spread: 4.50 (1.867%)
Market Cap: £142.05m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Trading Update

9 Jan 2014 07:00

RNS Number : 2582X
Gleeson(M J)Group PLC
09 January 2014
 



MJ GLEESON GROUP PLC

('Gleeson' or 'the Group')

TRADING UPDATE

 

MJ Gleeson Group plc (GLE.L), the urban regeneration and strategic land specialist, today issues the following trading update ahead of its interim results for the six months ended 31 December 2013, which are expected to be announced on Monday 17 February 2014.

 

The Group continues to trade well and expects profits for H1 2014 to show a strong increase over H1 2013. Beyond that, the Board is confident of delivering a result for the full year which is in line with current expectations.

 

Gleeson Homes

 

Gleeson Homes sold 258 homes during the period, an increase of 56% on the previous year's total of 165, and has a current forward order book of 240 homes.

 

The Government's Help to Buy initiative has continued to be attractive to our customers, with 44% of completions in the period benefitting from the scheme.

 

The business currently has 33 active sites, compared with 27 in the corresponding period. Gleeson Homes is in active discussions regarding the acquisition of further sites which, if purchased, will add 1,940 plots to the land pipeline, taking the total number of plots to in excess of 6,000.

 

Gleeson Strategic Land

 

Gleeson Strategic Land sold two sites in the period, with a combined acreage of four acres and planning permission for 42 plots. In addition, the division achieved planning permission on three sites which will deliver a combined total of 380 plots when the sites are sold in due course. Twelve planning applications with the potential to deliver a total of 1,737 plots were submitted during the period.

 

Also during the period, a further four land interests of 81 acres, with the potential to deliver 545 plots, were secured. The Gleeson Strategic Land portfolio now comprises 70 land interests of 3,781 gross acres, which have the potential to deliver 21,600 plots.

 

Jolyon Harrison, Chief Executive, commented:

 

"The first half performance of both Gleeson Homes and Gleeson Strategic Land has been encouraging, with first half profits expected to be strongly ahead of last year. The Group continues to benefit from our twin track strategy focussed on providing low cost family homes in the North of England, and strategic land promotion in the South."

 

9 January 2014

 

Enquiries:

 

MJ Gleeson Group plc

Tel: +44 1252 360 300

Jolyon Harrison

Chief Executive Officer

Alan Martin

Chief Financial Officer

College Hill

Tel: +44 20 7457 2020

Helen Tarbet

Mark Garraway

N+1 Singer

Shaun Dobson

Tel: +44 20 7496 3000

Gillian Martin

 

 

 

Notes to Editors

 

MJ Gleeson Group plc operates in the house building sector through the following business units; Gleeson Homes, which focuses on estate regeneration and housing development on brownfield land in the North of England; and Gleeson Strategic Land, which purchases options over land in the South of England with the objective of enhancing the value of the site concerned by securing residential planning permission.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSSFSMUFLSELF
Date   Source Headline
11th Jan 20224:38 pmRNSDirector/PDMR Shareholding
11th Jan 20227:00 amRNSNotice of Results & Trading Update
31st Dec 20217:00 amRNSTotal Voting Rights
8th Dec 20212:47 pmRNSDirector/PDMR Shareholding
30th Nov 20217:00 amRNSTotal Voting Rights
26th Nov 20214:50 pmRNSDirector/PDMR Shareholding - Amendment
26th Nov 20214:49 pmRNSDirector/PDMR Shareholding
15th Nov 202112:52 pmRNSResult of AGM
15th Nov 20217:00 amRNSAGM Statement
8th Nov 20211:50 pmRNSDirector/PDMR Shareholding
4th Nov 20214:35 pmRNSPrice Monitoring Extension
2nd Nov 20218:29 amRNSDirector/PDMR Shareholding
29th Oct 20217:00 amRNSTotal Voting Rights
26th Oct 20219:38 amRNSDirector/PDMR Shareholding
15th Oct 20214:41 pmRNSSecond Price Monitoring Extn
15th Oct 20214:36 pmRNSPrice Monitoring Extension
13th Oct 202112:48 pmRNSNotice of AGM
8th Oct 20211:22 pmRNSDirector/PDMR Shareholding
1st Oct 20217:00 amRNSPerformance Share Plan award to PDMRs
30th Sep 20217:00 amRNSTotal Voting Rights
28th Sep 20214:09 pmRNSPerformance Share Plan award to Directors
28th Sep 20214:06 pmRNSDirector/PDMR Shareholding
15th Sep 202110:33 amRNSDirector/PDMR Shareholding - Amendment
14th Sep 20217:00 amRNSAudited results for the year ended 30 June 2021
8th Sep 202111:14 amRNSDirector/PDMR Shareholding
31st Aug 20217:00 amRNSTotal Voting Rights
9th Aug 20214:37 pmRNSPrice Monitoring Extension
9th Aug 20211:11 pmRNSDirector/PDMR Shareholding
30th Jul 20217:00 amRNSTotal Voting Rights
21st Jul 20217:00 amRNSLong Term Incentive Plan award to Director
9th Jul 20219:41 amRNSDirector/PDMR Shareholding
9th Jul 20217:00 amRNSNotice of Results & Trading Update
7th Jul 20214:47 pmRNSDirector/PDMR Shareholding
30th Jun 20217:00 amRNSTotal Voting Rights
8th Jun 20214:44 pmRNSDirector/PDMR Shareholding
28th May 20217:00 amRNSTotal Voting Rights
24th May 20217:00 amRNSTrading Update
7th May 20214:33 pmRNSDirector/PDMR Shareholding
30th Apr 20217:00 amRNSTotal Voting Rights
9th Apr 20212:02 pmRNSDirector/PDMR Shareholding
31st Mar 20217:00 amRNSTotal Voting Rights
26th Mar 20214:08 pmRNSRe Committee appointments
22nd Mar 20218:34 amRNSPerformance Share Plan award to Directors/PDMRs
8th Mar 20211:44 pmRNSDirector/PDMR Shareholding
1st Mar 20217:00 amRNSRe Directorate
26th Feb 20217:00 amRNSTotal Voting Rights
11th Feb 20217:00 amRNSHalf-year Report
8th Feb 20215:07 pmRNSDirector/PDMR Shareholding
29th Jan 20217:00 amRNSTotal Voting Rights
11th Jan 20217:00 amRNSNotice of Results & Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.